Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 23.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 001414 | S. Lesage [France] ; C. Condroyer [France] ; S. Klebe [France] ; A. Honore [France] ; F. Tison [France] ; C. Brefel-Courbon [France] ; A. Diirr [France] ; A. Brice [France] | IDENTIFICATION OF VPS35 MUTATIONS REPLICATED IN FRENCH FAMILIES WITH PARKINSON DISEASE |
| 001855 | V. Marchand-Pauvert [France] ; A. Gerdelat-Mas [France] ; F. Ory-Magne [France] ; F. Calvas [France] ; D. Mazevet [France] ; S. Meunier [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; M. Simonetta-Moreau [France] | Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease |
| 001A08 | P. Payoux [France] ; C. Brefel-Courbon ; F. Ory-Magne ; W. Regragui ; C. Thalamas ; S. Balduyck ; F. Durif ; J P Azulay ; F. Tison ; O. Blin ; J P Esquerre ; O. Rascol | Motor activation in multiple system atrophy and Parkinson disease: a PET study. |
| 001D31 | P. Payoux [France] ; C. Brefel-Courbon [France] ; F. Ory-Magne [France] ; W. Regragui [France] ; C. Thalamas [France] ; S. Balduyck [France] ; F. Durif [France] ; J. P. Azulay [France] ; F. Tison [France] ; O. Blin [France] ; J. P. Esquerre [France] ; O. Rascol [France] | Motor activation in multiple system atrophy and Parkinson disease: A PET study |
| 001E67 | C. Brefel-Courbon [France] | [Digestive disturbances in Parkinson disease]. |
| 002060 | S. Lesage [France] ; C. Condroyer [France] ; A. Lannuzel [France] ; E. Lohmann [France] ; A. Troiano [France] ; F. Tison [France] ; P. Damier [France] ; S. Thobois [France] ; A-M Ouvrard-Hernandez [France] ; S. Rivaud-Péchoux [France] ; C. Brefel-Courbon [France] ; A. Destée [France] ; C. Tranchant [France] ; M. Romana ; L. Leclere [France] ; A. Dürr [France] ; A. Brice [France] | Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson’s disease |
| 002698 | A. Gerdelat-Mas [France] ; M. Simonetta-Moreau [France] ; C. Thalamas [France] ; F. Ory-Magne [France] ; T. Slaoui [France] ; O. Rascol [France] ; C. Brefel-Courbon [France] | Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study |
| 002776 | T. Slaoui [France] ; A. Mas-Gerdelat [France] ; F. Ory-Magne [France] ; O. Rascol [France] ; C. Brefel-Courbon [France] | La lévodopa modifie les seuils nociceptifs chez le patient parkinsonien |
| 002958 | J. J. Ferreira [Portugal] ; K. Desboeuf [France] ; M. Galitzky [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; N. Fabre [France] ; J. Senard [France] ; J. Montastruc [France] ; C. Sampaio [Portugal] ; O. Rascol [France] | Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: a clinical survey in PD patients and age‐matched healthy volunteers |
| 003081 | P. Cintas [France] ; M. Simonetta-Moreau ; F. Ory ; C. Brefel-Courbon ; N. Fabre ; P. Chaynes ; J. Sabatier ; J C Sol ; O. Rascol ; I. Berry ; Y. Lazorthes | Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contacts. |
| 003226 | Olivier Rascol [France] ; C. Brefel-Courbon [France] ; P. Payoux [France] ; J. Ferreira [Portugal] | The management of patients with early Parkinson's disease |
| 003313 | O. Rascol [France] ; P. Payoux ; J. Ferreira ; C. Brefel-Courbon | The management of patients with early Parkinson's disease. |
| 003572 | O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L Montastruc | The pharmacologic treatment of gait ignition failure. |
| 003828 | O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
| 003B07 | C. Brefel-Courbon [France] | Quelles stratégies médicamenteuses sont à conseiller à la phase évoluée de la maladie de Parkinson |
| 003C58 | O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L Montastruc | Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients. |
| 003F04 | C. Thalamas [France] ; A. Taylor [Royaume-Uni] ; C. Brefel-Courbon [France] ; S. Eagle [Royaume-Uni] ; K. Fitzpatrick [Royaume-Uni] ; O. Rascol [France] | Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease |
| 004109 | O. Rascol [France] ; C. Brefel-Courbon [France] ; O. Blin [France] | Pharmacologie clinique des dyskinésies induites par la L-dopa chez les malades parkinsoniens |
| 004128 | C. Brefel-Courbon [France] ; C. Thalamas [France] ; H. Peyro Saint Paul [France] ; J.-M. Senard [France] ; J.-L. Montastruc [France] ; O. Rascol [France] | α2-Adrenoceptor antagonists: A new approach to Parkinson's disease? |
| 004157 | J. L. Montastruc [France] ; M. Pelat [France] ; P. Verwaerde [France] ; C. Brefel-Courbon [France] ; M. A. Tran [France] ; O. Blin [France] ; O. Rascol [France] ; J. M. Senard [France] | Fluoxetine in orthostatic hypotension of Parkinson's disease : A clinical and experimental pilot study |
| 004366 | N. Fabre [France] ; C. Brefel-Courbon [France] ; O. Rascol [France] | Parkinson « plus » : Mouvements anormaux |
| 005926 | O. Rascol [France] ; C. Brefel-Courbon ; O. Blin | [Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients]. |
| 005945 | J L Montastruc [France] ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-Mestre | Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. |
| This area was generated with Dilib version V0.6.29. |  |